Abstract
Nature leads this week with a story about the Bush administration's surprisingly liberal overtures to Third World countries that want to develop inexpensive AIDS medications. Efforts to unify the European research effort are the focus of Science's lead article.
Highlights
Nature leads this week with a story about the Bush administrations surprisingly liberal overtures to Third World countries that want to develop inexpensive AIDS medications
Nature reports that Father Angelo dAgostino, head of Nyumbani Orphanage for children with HIV or AIDS in the Kenyan capital Nairobi, plans to start buying anti-AIDS drugs from the Indian company Cipla of Mumbai, which has promised to make the drugs available at about one-third of the minimum cost on offer from the Western companies
Big Pharma is not happy about the cheap drugs - 42 pharmaceutical companies are currently challenging a South African decision to allow domestic production of generic AIDS drugs - the previous US administration had adopted a relaxed attitude toward countries wishing to produce their own versions of expensive Western AIDS drugs, says Nature
Summary
Nature leads this week with a story about the Bush administrations surprisingly liberal overtures to Third World countries that want to develop inexpensive AIDS medications. Efforts to unify the European research effort are the focus of Sciences lead article. AIDS has ravaged many African and South American countries in the past several years.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.